NeoGenomics Earnings Report: Q4 Overview

-6.67%

NeoGenomics, Inc.

NEO

7.98

-6.67%

The Q4 earnings report for NeoGenomics (NASDAQ:NEO) was released on Tuesday, February 17, 2026 at 07:05 AM.

Here's what investors need to know about the latest announcement.

Earnings

NeoGenomics beat estimated earnings by 500.0%, reporting an EPS of $0.06 versus an estimate of $0.01.

Revenue was up $18.17 million from the same period last year.

Past Earnings Performance

The company beat on EPS by $0.04 in the previous quarter, leading to a 3.63% increase share price change the next day.

Here's a look at NeoGenomics's past performance:

Quarter	Q3 2025	Q2 2025	Q1 2025	Q4 2024
EPS Estimate	-0.01	-0.01	-0.01	0.03
EPS Actual	0.03	0.03	0	0.04
Revenue Estimate	183.76M	182.76M	170.90M	173.40M
Revenue Actual	187.80M	181.33M	168.03M	172.00M

To track all earnings releases for NeoGenomics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

More This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.